Molecular Mechanisms of Action of Functional Foods and Nutraceuticals for Chronic Diseases (PDF)

Shima Abdollahi, PhD, is currently assistant professor in North Khorasan University of Medical Sciences, Bojnurd, Iran. She earned her BS, MS and PhD degrees in nutrition sciences from Tabriz, Tehran, and Shahid Sadoughi universities of medical sciences, respectively. She received a research grant from Iran national science foundation (INSF) for her doctoral thesis on the effect of resveratrol supplementation in patients with diabetes. Shima has experience in gene expression studies, as well as systematic review and meta-analysis studies.

Dr. Syam Mohan is currently working as an Associate Professor at Jazan University, Saudi Arabia. Before that, he was at the University of Malaya, the oldest and premier public university in Malaysia. He graduated from TN DR MGR Medical University, India, in 2003. In 2007 he joined MS Pharmacology. His research outcomes were so outstanding that his Master's degree was upgraded to Ph.D. with a fellowship, awarded by University Putra Malaysia. He undertook a year of senior research fellowship (Postdoctoral) at the University of Malaya, later joined the Department of Pharmacy as Associate Professor, and established the pharmaceutical biology research group in the Pharmacology Unit. His specific expertise is focused on the pharmacology of cancer and inflammation. He acquired an overall H-index of 40 with his high number of research publications (120) in ISI-cited journals. Dr. Syam, the author of one book, also holds two patents. He was also one of the two selected participants from Asia who received a fellowship to attend the FEBS Advanced Lecture Course on Translational Cancer Research at Portugal organized by the Federation of European Biochemical Society, UK, and was a member of the European Association of Cancer Research (EACR) and is an active member of Malaysian Biochemistry and Molecular Biology Society (MBMBS). He has organized several workshops and seminars and has attracted over US$ 250 000 as research funding so